YM 900

YM 90K

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Umemura K, Kondo K, Ikeda Y, et al. Pharmacokinetics and safety of the novel amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist YM90K in healthy men. J Clin Pharmacol 1997 Aug; 37: 719–27
PubMed CAS Google Scholar
Katoh M, Kawasaki-Yatsugi S, Koshiya K, et al. Anti-convulsive and anti-hypoxic effects of YM90K, a selective and potent AMPA/kainate receptor antagonist. Jpn J Pharmacol 1994; 64 Suppl. 1: 207
Google Scholar
Kawasaki S, Yatsugi S-I, Takahashi M, et al. Postischemic administration of YM900, a selective and potent alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate receptor antagonist, prevents delayed neuronal death in gerbil hippocampus. Jpn J Pharmacol 1993; 61 Suppl. I: 284P
Google Scholar

YM 900. Drugs R&D 1, 42–43 (1999). https://doi.org/10.2165/00126839-199901010-00017

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.